• 9548 Citations
  • 31 Scopus h-Index
20022020

Research output per year

If you made any changes in Pure these will be visible here soon.

Research Output

Filter
Article
2002

Three hundred consecutive emergent celiotomies in general surgery patients: Influence of advanced diagnostic imaging techniques and procedures on diagnosis

Rozycki, G. S., Tremblay, L., Feliciano, D. V., Joseph, R., DeDelva, P., Salomone, J. P., Nicholas, J. M., Cava, R. A., Ansley, J. D. & Ingram, W. L., May 9 2002, In : Annals of surgery. 235, 5, p. 681-689 9 p.

Research output: Contribution to journalArticle

21 Scopus citations
2011

High incidence of vitamin D deficiency in patients undergoing allogeneic stem cell transplantation

Joseph, R. W., Alousi, A., Konda, B., Komanduri, K., Neumann, J., Trevino, C., Stolar, K., Qazilbash, M., Hosing, C., Kebriaei, P., Couriel, D. R., Champlin, R. E., Saliba, R. & Popat, U., Nov 1 2011, In : American journal of hematology. 86, 11, p. 954-956 3 p.

Research output: Contribution to journalArticle

18 Scopus citations

Impact of clinical and pathologic features on tumor-infiltrating lymphocyte expansion from surgically excised melanoma metastases for adoptive T-cell therapy

Joseph, R. W., Peddareddigari, V. R., Liu, P., Miller, P. W., Overwijk, W. W., Bekele, N. B., Ross, M. I., Lee, J. E., Gershenwald, J. E., Lucci, A., Prieto, V. G., McMannis, J. D., Papadopoulos, N., Kim, K., Homsi, J., Bedikian, A., Hwu, W. J., Hwu, P. & Radvanyi, L. G., Jul 15 2011, In : Clinical Cancer Research. 17, 14, p. 4882-4891 10 p.

Research output: Contribution to journalArticle

35 Scopus citations
2012

A randomized phase II study of cilengitide (EMD 121974) in patients with metastatic melanoma

Kim, K. B., Prieto, V., Joseph, R. W., Diwan, A. H., Gallick, G. E., Papadopoulos, N. E., Bedikian, A. Y., Camacho, L. H., Hwu, P., Ng, C. S., Wei, W., Johnson, M. M., Wittemer, S. M., Vardeleon, A., Reckeweg, A. & Colevas, A. D., Aug 1 2012, In : Melanoma research. 22, 4, p. 294-301 8 p.

Research output: Contribution to journalArticle

36 Scopus citations

Characterizing the clinical benefit of ipilimumab in patients who progressed on high-dose IL-2

Joseph, R. W., Eckel-Passow, J. E., Sharma, R., Liu, P., Parker, A., Jakob, J., Buchbinder, E., Bassett, R. L., Davies, M. A., Hwu, P., Atkins, M. B. & Sullivan, R. J., Nov 1 2012, In : Journal of Immunotherapy. 35, 9, p. 711-715 5 p.

Research output: Contribution to journalArticle

16 Scopus citations

NRAS mutation status is an independent prognostic factor in metastatic melanoma

Jakob, J. A., Bassett, R. L., Ng, C. S., Curry, J. L., Joseph, R. W., Alvarado, G. C., Rohlfs, M. L., Richard, J., Gershenwald, J. E., Kim, K. B., Lazar, A. J., Hwu, P. & Davies, M. A., Aug 15 2012, In : Cancer. 118, 16, p. 4014-4023 10 p.

Research output: Contribution to journalArticle

400 Scopus citations

Oncogenic BRAF(V600E) promotes stromal cell-mediated immunosuppression via induction of interleukin-1 in melanoma

Khalili, J. S., Liu, S., Rodríguez-Cruz, T. G., Whittington, M., Wardell, S., Liu, C., Zhang, M., Cooper, Z. A., Frederick, D. T., Li, Y., Zhang, M., Joseph, R. W., Bernatchez, C., Ekmekcioglu, S., Grimm, E., Radvanyi, L. G., Davis, R. E., Davies, M. A., Wargo, J. A., Hwu, P. & 1 others, Lizée, G., Oct 1 2012, In : Clinical Cancer Research. 18, 19, p. 5329-5340 12 p.

Research output: Contribution to journalArticle

168 Scopus citations

Vitamin D receptor upregulation in alloreactive human T cells

Joseph, R. W., Bayraktar, U. D., Kim, T. K., John, S. L. S., Popat, U., Khalili, J., Molldrem, J. J., Wieder, E. D. & Komanduri, K. V., Jul 1 2012, In : Human Immunology. 73, 7, p. 693-698 6 p.

Research output: Contribution to journalArticle

19 Scopus citations
2013

Age-period-cohort analysis of renal cell carcinoma in United States adults

Tyson, M. D., Humphreys, M. R., Parker, A. S., Thiel, D. D., Joseph, R. W., Andrews, P. E. & Castle, E. P., Jul 1 2013, In : Urology. 82, 1, p. 43-47 5 p.

Research output: Contribution to journalArticle

18 Scopus citations

An integrated model of the transcriptome of HER2-positive breast cancer

Kalari, K. R., Necela, B. M., Tang, X., Thompson, K. J., Lau, M., Eckel-Passow, J. E., Kachergus, J. M., Keith Anderson, S., Sun, Z., Baheti, S., Carr, J. M., Baker, T. R., Barman, P., Radisky, D. C., Joseph, R. W., McLaughlin, S. A., Chai, H. S., Camille, S., Rossell, D., Asmann, Y. W. & 2 others, Aubrey Thompson, E. & Perez, E. A., Nov 1 2013, In : PloS one. 8, 11, e79298.

Research output: Contribution to journalArticle

11 Scopus citations

Evaluation of the association of prostate cancer-specific anxiety with sexual function, depression and cancer aggressiveness in men 1 year following surgical treatment for localized prostate cancer

Tavlarides, A. M., Ames, S. C., Diehl, N. N., Joseph, R. W., Castle, E. P., Thiel, D. D., Broderick, G. A. & Parker, A. S., Jun 1 2013, In : Psycho-Oncology. 22, 6, p. 1328-1335 8 p.

Research output: Contribution to journalArticle

23 Scopus citations

Inverse association between programmed death ligand 1 and genes in the VEGF pathway in primary clear cell renal cell carcinoma

Joseph, R. W., Parasramka, M., Eckel-Passow, J. E., Serie, D., Wu, K., Jiang, L., Kalari, K., Thompson, R. H., Huu Ho, T., Castle, E. P., Cheville, J., Kwon, E. D., Thompson, E. A. & Parker, A., Dec 1 2013, In : Cancer Immunology Research. 1, 6, p. 378-385 8 p.

Research output: Contribution to journalArticle

22 Scopus citations
22 Scopus citations

Safety and tumor responses with lambrolizumab (anti-PD-1) in melanoma

Hamid, O., Robert, C., Daud, A., Hodi, F. S., Hwu, W. J., Kefford, R., Wolchok, J. D., Hersey, P., Joseph, R. W., Weber, J. S., Dronca, R., Gangadhar, T. C., Patnaik, A., Zarour, H., Joshua, A. M., Gergich, K., Elassaiss-Schaap, J., Algazi, A., Mateus, C., Boasberg, P. & 6 others, Tumeh, P. C., Chmielowski, B., Ebbinghaus, S. W., Li, X. N., Kang, S. P. & Ribas, A., Jan 1 2013, In : New England Journal of Medicine. 369, 2, p. 134-144 11 p.

Research output: Contribution to journalArticle

2231 Scopus citations

Severe cutaneous and neurologic toxicity in melanoma patients during vemurafenib administration following anti-PD-1 therapy

Johnson, D. B., Wallender, E. K., Cohen, D. N., Likhari, S. S., Zwerner, J. P., Powers, J. G., Shinn, L., Kelley, M. C., Joseph, R. W. & Sosman, J. A., Dec 1 2013, In : Cancer immunology research. 1, 6, p. 373-377 5 p.

Research output: Contribution to journalArticle

66 Scopus citations

Ultrathin primary is a marker for worse prognosis in lymph node-positive cutaneous melanoma

Bagaria, S. P., Ray, P. S., Joseph, R. W., Heckman, M. G., Rawal, B., Gray, R. J., Pockaj, B. & Wasif, N., May 15 2013, In : Cancer. 119, 10, p. 1860-1867 8 p.

Research output: Contribution to journalArticle

6 Scopus citations
2014

ANKS1B is a smoking-related molecular alteration in clear cell renal cell carcinoma

Eckel-Passow, J. E., Serie, D. J., Bot, B. M., Joseph, R. W., Cheville, J. C. & Parker, A. S., Jan 31 2014, In : BMC Urology. 14, 1, 14.

Research output: Contribution to journalArticle

19 Scopus citations

Anti-programmed-death-receptor-1 treatment with pembrolizumab in ipilimumab-refractory advanced melanoma: A randomised dose-comparison cohort of a phase 1 trial

Robert, C., Ribas, A., Wolchok, J. D., Hodi, F. S., Hamid, O., Kefford, R., Weber, J. S., Joshua, A. M., Hwu, W. J., Gangadhar, T. C., Patnaik, A., Dronca, R., Zarour, H., Joseph, R. W., Boasberg, P., Chmielowski, B., Mateus, C., Postow, M. A., Gergich, K., Elassaiss-Schaap, J. & 5 others, Li, X. N., Iannone, R., Ebbinghaus, S. W., Kang, S. P. & Daud, A., Sep 20 2014, In : The Lancet. 384, 9948, p. 1109-1117 9 p.

Research output: Contribution to journalArticle

1123 Scopus citations

C-MET expression in primary and liver metastases in uveal melanoma

Gardner, F. P., Serie, D. J., Salomao, D. R., Wu, K. J., Markovic, S. N., Pulido, J. S. & Joseph, R. W., Dec 10 2014, In : Melanoma research. 24, 6, p. 617-620 4 p.

Research output: Contribution to journalArticle

17 Scopus citations

Higher expression of topoisomerase II alpha is an independent marker of increased risk of cancer-specific death in patients with clear cell renal cell carcinoma

Parker, A. S., Eckel-Passow, J. E., Serie, D., Hilton, T., Parasramka, M., Joseph, R. W., Wu, K. J., Cheville, J. C. & Leibovich, B. C., Nov 1 2014, In : European urology. 66, 5, p. 929-935 7 p.

Research output: Contribution to journalArticle

19 Scopus citations

Loss of BAP1 protein expression is an independent marker of poor prognosis in patients with low-risk clear cell renal cell carcinoma

Joseph, R. W., Kapur, P., Serie, D. J., Eckel-Passow, J. E., Parasramka, M., Ho, T., Cheville, J. C., Frenkel, E., Rakheja, D., Brugarolas, J. & Parker, A., Jan 1 2014, In : Cancer. 120, 7, p. 1059-1067 9 p.

Research output: Contribution to journalArticle

75 Scopus citations

Somatic expression of ENRAGE is associated with obesity status among patients with clear cell renal cell carcinoma

Eckel-Passow, J. E., Serie, D. J., Bot, B. M., Joseph, R. W., Hart, S. N., Cheville, J. C. & Parker, A. S., Apr 2014, In : Carcinogenesis. 35, 4, p. 822-827 6 p.

Research output: Contribution to journalArticle

12 Scopus citations
2015

A multidisciplinary biospecimen bank of renal cell carcinomas compatible with discovery platforms at Mayo Clinic, Scottsdale, Arizona

Ho, T. H., Nateras, R. N., Yan, H. D., Park, J. G., Jensen, S., Borges, C., Lee, J. H., Champion, M. D., Tibes, R., Bryce, A. H., Carballido, E. M., Todd, M. A., Joseph, R. W., Wong, W. W., Parker, A., Stanton, M. L. & Castle, E. P., Jul 16 2015, In : PLoS One. 10, 7, e0132831.

Research output: Contribution to journalArticle

6 Scopus citations

Assessing the clinical use of clear cell renal cell carcinoma molecular subtypes identified by RNA expression analysis

Eckel-Passow, J. E., Igel, D. A., Serie, D. J., Joseph, R. W., Ho, T. H., Cheville, J. C. & Parker, A., Feb 1 2015, In : Urologic Oncology. 33, 2

Research output: Contribution to journalArticle

5 Scopus citations
2 Scopus citations

Current state of anti-PD-L1 and anti-PD-1 agents in cancer therapy

Swaika, A., Hammond, W. A. & Joseph, R. W., Oct 1 2015, In : Molecular Immunology. 67, 2, p. 4-17 14 p.

Research output: Contribution to journalArticle

127 Scopus citations

Follicular dendritic cell sarcoma presenting as a thyroid mass

Starr, J. S., Attia, S., Joseph, R. W., Menke, D., Casler, J. & Smallridge, R. C., Jun 10 2015, In : Journal of Clinical Oncology. 33, 17, p. e74-e76

Research output: Contribution to journalArticle

10 Scopus citations

High-resolution profiling of histone h3 lysine 36 trimethylation in metastatic renal cell carcinoma

Ho, T. H., Park, I. Y., Zhao, H., Tong, P., Champion, M. D., Yan, H. D., Monzon, F. A., Hoang, A., Tamboli, P., Parker, A., Joseph, R. W., Qiao, W., Dykema, K., Tannir, N. M., Castle, E. P., Nunez-Nateras, R., Teh, B. T., Wang, J., Walker, C. L., Hung, M. C. & 1 others, Jonasch, E., Jun 15 2015, (Accepted/In press) In : Oncogene.

Research output: Contribution to journalArticle

33 Scopus citations

Lichenoid dermatitis in three patients with metastatic melanoma treated with anti-PD-1 therapy

Joseph, R. W., Cappel, M., Goedjen, B., Gordon, M., Kirsch, B., Gilstrap, C., Bagaria, S. & Jambusaria-Pahlajani, A., Jan 1 2015, In : Cancer immunology research. 3, 1, p. 18-22 5 p.

Research output: Contribution to journalArticle

62 Scopus citations

Loss of PBRM1 and BAP1 expression is less common in non-clear cell renal cell carcinoma than in clear cell renal cell carcinoma

Ho, T. H., Kapur, P., Joseph, R. W., Serie, D. J., Eckel-Passow, J. E., Parasramka, M., Cheville, J. C., Wu, K. J., Frenkel, E., Rakheja, D., Stefanius, K., Brugarolas, J. & Parker, A. S., Jan 1 2015, In : Urologic Oncology: Seminars and Original Investigations. 33, 1, p. 23.e9-23.e14

Research output: Contribution to journalArticle

25 Scopus citations

Management of metastatic apocrine hidradenocarcinoma with chemotherapy and radiation

Miller, D. H., Peterson, J. L., Buskirk, S. J., Vallow, L. A., Ta, R., Joseph, R. W., Krishna, M., Ko, S. J. & Tzou, K. S., 2015, In : Rare Tumors. 7, 3, p. 133-135 3 p.

Research output: Contribution to journalArticle

6 Scopus citations

Negative Sentinel Lymph Node Biopsy in Merkel Cell Carcinoma is Associated with a Low Risk of Same-Nodal-Basin Recurrences

Grotz, T. E., Joseph, R. W., Pockaj, B. A., Foote, R. L., Otley, C. C., Bagaria, S. P., Weaver, A. L. & Jakub, J. W., Feb 13 2015, In : Annals of Surgical Oncology. 22, 12, p. 4060-4066 7 p.

Research output: Contribution to journalArticle

21 Scopus citations

PD-1 and PD-L1 expression in renal cell carcinoma with sarcomatoid differentiation

Joseph, R. W., Millis, S. Z., Carballido, E. M., Bryant, D., Gatalica, Z., Reddy, S., Bryce, A. H., Vogelzang, N. J., Stanton, M. L., Castle, E. P. & Ho, T. H., Dec 1 2015, In : Cancer immunology research. 3, 12, p. 1303-1307 5 p.

Research output: Contribution to journalArticle

71 Scopus citations

Pilot trial of selecting molecularly guided therapy for patients with non-V600 BRAF-mutant metastatic melanoma: Experience of the SU2C/MRA melanoma dream team

LoRusso, P. M., Boerner, S. A., Pilat, M. J., Forman, K. M., Zuccaro, C. Y., Kiefer, J. A., Liang, W. S., Hunsberger, S., Redman, B. G., Markovic, S. N., Sekulic, A. D., Bryce, A. H., Joseph, R. W., Cowey, C. L., Fecher, L. A., Sosman, J. A., Chapman, P. B., Schwartz, G. K., Craig, D. W., Carpten, J. D. & 1 others, Trent, J. M., Aug 1 2015, In : Molecular Cancer Therapeutics. 14, 8, p. 1962-1971 10 p.

Research output: Contribution to journalArticle

16 Scopus citations

Steroid hormone influence on melanomagenesis

Mitkov, M., Joseph, R. W. & Copland, J. A. III., Dec 5 2015, In : Molecular and Cellular Endocrinology. 417, p. 94-102 9 p.

Research output: Contribution to journalArticle

21 Scopus citations

Whole exome sequencing of a patient with metastatic hidradenocarcinoma and review of the literature

Gupta, E., Guthrie, K. J., Krishna, M., Asmann, Y., Parker, A. S. & Joseph, R. W., Jan 1 2015, In : Rare Tumors. 7, 1, p. 29-33 5 p.

Research output: Contribution to journalArticle

1 Scopus citations
2016

Association of pembrolizumab with tumor response and survival among patients with advanced melanoma

Ribas, A., Hamid, O., Daud, A., Hodi, F. S., Wolchok, J. D., Kefford, R., Joshua, A. M., Patnaik, A., Hwu, W. J., Weber, J. S., Gangadhar, T. C., Hersey, P., Dronca, R. S., Joseph, R. W., Zarour, H., Chmielowski, B., Lawrence, D. P., Algazi, A., Rizvi, N. A., Hoffner, B. & 8 others, Mateus, C., Gergich, K., Lindia, J. A., Giannotti, M., Li, X. N., Ebbinghaus, S., Kang, S. P. & Robert, C., Apr 19 2016, In : JAMA - Journal of the American Medical Association. 315, 15, p. 1600-1609 10 p.

Research output: Contribution to journalArticle

469 Scopus citations

A Study of Combination Bicalutamide and Raloxifene for Patients With Castration-Resistant Prostate Cancer

Ho, T. H., Nunez-Nateras, R., Hou, Y. X., Bryce, A. H., Northfelt, D. W., Dueck, A., Wong, B., Stanton, M. L., Joseph, R. W. & Castle, E. P., Jul 8 2016, (Accepted/In press) In : Clinical Genitourinary Cancer.

Research output: Contribution to journalArticle

3 Scopus citations

Atezolizumab in patients with locally advanced and metastatic urothelial carcinoma who have progressed following treatment with platinum-based chemotherapy: A single-arm, multicentre, phase 2 trial

Rosenberg, J. E., Hoffman-Censits, J., Powles, T., Van Der Heijden, M. S., Balar, A. V., Necchi, A., Dawson, N., O'Donnell, P. H., Balmanoukian, A., Loriot, Y., Srinivas, S., Retz, M. M., Grivas, P., Joseph, R. W., Galsky, M. D., Fleming, M. T., Petrylak, D. P., Perez-Gracia, J. L., Burris, H. A., Castellano, D. & 11 others, Canil, C., Bellmunt, J., Bajorin, D., Nickles, D., Bourgon, R., Frampton, G. M., Cui, N., Mariathasan, S., Abidoye, O., Fine, G. D. & Dreicer, R., May 7 2016, In : The Lancet. 387, 10031, p. 1909-1920 12 p.

Research output: Contribution to journalArticle

1557 Scopus citations

Clear Cell Renal Cell Carcinoma Subtypes Identified by BAP1 and PBRM1 Expression

Joseph, R. W., Kapur, P., Serie, D. J., Parasramka, M., Ho, T. H., Cheville, J. C., Frenkel, E., Parker, A. & Brugarolas, J., Jan 1 2016, In : Journal of Urology. 195, 1, p. 180-187 8 p.

Research output: Contribution to journalArticle

62 Scopus citations

Clear Cell Type A and B Molecular Subtypes in Metastatic Clear Cell Renal Cell Carcinoma: Tumor Heterogeneity and Aggressiveness

Serie, D. J., Joseph, R. W., Cheville, J. C., Ho, T. H., Parasramka, M., Hilton, T., Thompson, R. H., Leibovich, B. C., Parker, A. & Eckel-Passow, J. E., 2016, (Accepted/In press) In : European Urology.

Research output: Contribution to journalArticle

17 Scopus citations

Correlation Between Molecular Subclassifications of Clear Cell Renal Cell Carcinoma and Targeted Therapy Response

Ho, T. H., Choueiri, T. K., Wang, K., Karam, J. A., Chalmers, Z., Frampton, G., Elvin, J. A., Johnson, A., Liu, X., Lin, Y., Joseph, R. W., Stanton, M. L., Miller, V. A., Stephens, P. J., Ross, J. S., Ali, S. M. & Pal, S. K., Jun 1 2016, In : European Urology Focus. 2, 2, p. 204-209 6 p.

Research output: Contribution to journalArticle

19 Scopus citations

Detection of tumor-associated cells in cryopreserved peripheral blood mononuclear cell samples for retrospective analysis

Zhu, P., Stanton, M. L., Castle, E. P., Joseph, R. W., Adams, D. L., Li, S., Amstutz, P., Tang, C. M. & Ho, T. H., Jul 2 2016, In : Journal of Translational Medicine. 14, 1, 198.

Research output: Contribution to journalArticle

8 Scopus citations

Evaluation of immune-related response criteria and RECIST v1.1 in patients with advanced melanoma treated with Pembrolizumab

Hodi, F. S., Hwu, W. J., Kefford, R., Weber, J. S., Daud, A., Hamid, O., Patnaik, A., Ribas, A., Robert, C., Gangadhar, T. C., Joshua, A. M., Hersey, P., Dronca, R. S., Joseph, R. W., Hille, D., Xue, D., Li, X. N., Kang, S. P., Ebbinghaus, S., Perrone, A. & 1 others, Wolchok, J. D., May 1 2016, In : Journal of Clinical Oncology. 34, 13, p. 1510-1517 8 p.

Research output: Contribution to journalArticle

361 Scopus citations

Loss of histone H3 lysine 36 trimethylation is associated with an increased risk of renal cell carcinoma-specific death

Ho, T. H., Kapur, P., Joseph, R. W., Serie, D. J., Eckel-Passow, J. E., Tong, P., Wang, J., Castle, E. P., Stanton, M. L., Cheville, J. C., Jonasch, E., Brugarolas, J. & Parker, A., Jan 1 2016, In : Modern Pathology. 29, 1, p. 34-42 9 p.

Research output: Contribution to journalArticle

21 Scopus citations

Melanoma, version 2.2016 clinical practice guidelines in oncology

Coit, D. G., Thompson, J. A., Algazi, A., Andtbacka, R., Bichakjian, C. K., Carson, W. E., Daniels, G. A., DiMaio, D., Ernstoff, M., Fields, R. C., Fleming, M. D., Gonzalez, R., Guild, V., Halpern, A. C., Hodi, F. S., Joseph, R. W., Lange, J. R., Martini, M. C., Materin, M. A., Olszanski, A. J. & 11 others, Ross, M. I., Salama, A. K., Skitzki, J., Sosman, J., Swetter, S. M., Tanabe, K. K., Torres-Roca, J. F., Trisal, V., Urist, M. M., McMillian, N. & Engh, A., Apr 1 2016, In : JNCCN Journal of the National Comprehensive Cancer Network. 14, 4, p. 450-473 24 p.

Research output: Contribution to journalArticle

Open Access
130 Scopus citations

NCCN Guidelines® insights: Melanoma, version 3.2016: Featured updates to the NCCN Guidelines

Coit, D. G., Thompson, J. A., Algazi, A., Andtbacka, R., Bichakjian, C. K., Iii, W. E. C., Daniels, G. A., Dimaio, D., Fields, R. C., Fleming, M. D., Gastman, B., Gonzalez, R., Guild, V., Johnson, D., Joseph, R. W., Lange, J. R., Martini, M. C., Materin, M. A., Olszanski, A. J., Ott, P. & 11 others, Gupta, A. P., Ross, M. I., Salama, A. K., Skitzki, J., Swetter, S. M., Tanabe, K. K., Torres-Roca, J. F., Trisal, V., Urist, M. M., McMillian, N. & Engh, A., Aug 1 2016, In : JNCCN Journal of the National Comprehensive Cancer Network. 14, 8, p. 945-958 14 p.

Research output: Contribution to journalArticle

Open Access
51 Scopus citations

Programmed death-ligand 1 expression and response to the anti-programmed death 1 antibody pembrolizumab in melanoma

Daud, A. I., Wolchok, J. D., Robert, C., Hwu, W. J., Weber, J. S., Ribas, A., Hodi, F. S., Joshua, A. M., Kefford, R., Hersey, P., Joseph, R. W., Gangadhar, T. C., Dronca, R. S., Patnaik, A., Zarour, H., Roach, C., Toland, G., Lunceford, J. K., Li, X. N., Emancipator, K. & 4 others, Dolled-Filhart, M., Kang, S. P., Ebbinghaus, S. & Hamid, O., Dec 1 2016, In : Journal of Clinical Oncology. 34, 34, p. 4102-4109 8 p.

Research output: Contribution to journalArticle

241 Scopus citations

Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of renal cell carcinoma

Rini, B. I., McDermott, D. F., Hammers, H., Bro, W., Bukowski, R. M., Faba, B., Faba, J., Figlin, R. A., Hutson, T., Jonasch, E., Joseph, R. W., Leibovich, B. C., Olencki, T., Pantuck, A. J., Quinn, D. I., Seery, V., Voss, M. H., Wood, C. G., Wood, L. S. & Atkins, M. B., Nov 15 2016, In : Journal for ImmunoTherapy of Cancer. 4, 1, 81.

Research output: Contribution to journalArticle

29 Scopus citations

Treatment of in-transit and metastatic melanoma in two patients treated with ipilimumab and topical imiquimod

Joseph, R. W., Cappel, M., Tzou, K., Bagaria, S., Gilstrap, C., Swaika, A. & Jambusaria-Pahlajani, A., Aug 1 2016, In : Melanoma Research. 26, 4, p. 409-412 4 p.

Research output: Contribution to journalArticle

11 Scopus citations